Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 3/2021

15.04.2021 | case report

Sphenoidal mucormycosis associated with large B-cell lymphoma: case report and literature review

verfasst von: MD Anis Chaari, Esraa Turak, Mark Nashaat, Islam Aboayana, Vipin Kauts

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Mucormycosis is a rare but potentially life-threatening disease. Common risk factors include diabetic ketoacidosis, malignancies and bone marrow transplant. In patients with hematological malignancies mucormycosis often occurs in a context of neutropenia and/or following chemotherapy. We report a case of sphenoidal mucormycosis in a patient with large B‑cell lymphoma. This complication happened before any chemotherapy. The patient had normal neutrophils count and his diabetes was well controlled. Clinical course and management are discussed along with a review of the literature.

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Literatur
1.
Zurück zum Zitat Itoh M, et al. Disseminated mucormycosis infection after the first course of dose-modified R‑EPOCH for advanced-stage lymphoma. Kansenshogaku Zasshi. 2014;88(6 Suppl 11):7–10. PubMed Itoh M, et al. Disseminated mucormycosis infection after the first course of dose-modified R‑EPOCH for advanced-stage lymphoma. Kansenshogaku Zasshi. 2014;88(6 Suppl 11):7–10. PubMed
2.
Zurück zum Zitat Roden MM, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–53. CrossRef Roden MM, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–53. CrossRef
3.
Zurück zum Zitat Tryfon S, et al. Rhinocerebral mucormycosis in a patient with latent diabetes mellitus: a case report. J Oral Maxillofac Surg. 2002;60(3):328–30. CrossRef Tryfon S, et al. Rhinocerebral mucormycosis in a patient with latent diabetes mellitus: a case report. J Oral Maxillofac Surg. 2002;60(3):328–30. CrossRef
4.
Zurück zum Zitat Alacacioglu I, et al. Fatal disseminated mucormycosis in a patient with mantle cell non-Hodgkin’s lymphoma: an autopsy case. Braz J Infect Dis. 2009;13(3):238–41. CrossRef Alacacioglu I, et al. Fatal disseminated mucormycosis in a patient with mantle cell non-Hodgkin’s lymphoma: an autopsy case. Braz J Infect Dis. 2009;13(3):238–41. CrossRef
5.
Zurück zum Zitat Cornely OA, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014;20(Suppl 3):5–26. CrossRef Cornely OA, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014;20(Suppl 3):5–26. CrossRef
6.
Zurück zum Zitat Bahloul M, et al. Rhinocerebral mucormycosis complicated by hemophagocytic lymphohistiocytosis: case report from Tunisia. Med Sante Trop. 2012;22(2):210–2. PubMed Bahloul M, et al. Rhinocerebral mucormycosis complicated by hemophagocytic lymphohistiocytosis: case report from Tunisia. Med Sante Trop. 2012;22(2):210–2. PubMed
7.
Zurück zum Zitat Chaari A, et al. Mucormycosis: an unusual cause of unilateral exophthalmia. J Mycol Med. 2013;23(2):140–3. CrossRef Chaari A, et al. Mucormycosis: an unusual cause of unilateral exophthalmia. J Mycol Med. 2013;23(2):140–3. CrossRef
8.
Zurück zum Zitat Hilal AA, Taj-Aldeen SJ, Mirghani AH. Rhinoorbital mucormycosis secondary to Rhizopus oryzae: a case report and literature review. Ear Nose Throat J. 2004;83(8):556–558–60, 562. CrossRef Hilal AA, Taj-Aldeen SJ, Mirghani AH. Rhinoorbital mucormycosis secondary to Rhizopus oryzae: a case report and literature review. Ear Nose Throat J. 2004;83(8):556–558–60, 562. CrossRef
9.
Zurück zum Zitat Valentine JC, et al. A population-based analysis of invasive fungal disease in haematology-oncology patients using data linkage of state-wide registries and administrative databases: 2005–2016. BMC Infect Dis. 2019;19(1):274. CrossRef Valentine JC, et al. A population-based analysis of invasive fungal disease in haematology-oncology patients using data linkage of state-wide registries and administrative databases: 2005–2016. BMC Infect Dis. 2019;19(1):274. CrossRef
10.
Zurück zum Zitat Chamilos G, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989–2003). Haematologica. 2006;91(7):986–9. PubMed Chamilos G, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989–2003). Haematologica. 2006;91(7):986–9. PubMed
11.
Zurück zum Zitat Nosari A, et al. Mucormycosis in hematologic malignancies: an emerging fungal infection. Haematologica. 2000;85(10):1068–71. PubMed Nosari A, et al. Mucormycosis in hematologic malignancies: an emerging fungal infection. Haematologica. 2000;85(10):1068–71. PubMed
12.
Zurück zum Zitat Pagano L, et al. Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Gimema Infection Program (Gruppo Italiano Malattie Ematologiche dell’Adulto). Br J Haematol. 1995;89(3):500–5. CrossRef Pagano L, et al. Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Gimema Infection Program (Gruppo Italiano Malattie Ematologiche dell’Adulto). Br J Haematol. 1995;89(3):500–5. CrossRef
13.
Zurück zum Zitat Spellberg B, Edwards J Jr., Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18(3):556–69. CrossRef Spellberg B, Edwards J Jr., Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18(3):556–69. CrossRef
14.
Zurück zum Zitat Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest. 1984;74(1):150–60. CrossRef Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest. 1984;74(1):150–60. CrossRef
15.
Zurück zum Zitat Lewis RE, et al. Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses. 2013;56(6):638–45. CrossRef Lewis RE, et al. Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses. 2013;56(6):638–45. CrossRef
16.
Zurück zum Zitat Pagano L, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto). Br J Haematol. 1997;99(2):331–6. CrossRef Pagano L, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto). Br J Haematol. 1997;99(2):331–6. CrossRef
17.
Zurück zum Zitat Lerchenmüller C, et al. Rhinocerebral zygomycosis in a patient with acute lymphoblastic leukemia. Ann Oncol. 2001;12(3):415–9. CrossRef Lerchenmüller C, et al. Rhinocerebral zygomycosis in a patient with acute lymphoblastic leukemia. Ann Oncol. 2001;12(3):415–9. CrossRef
18.
Zurück zum Zitat Nithyanandam S, et al. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol. 2003;51(3):231–6. PubMed Nithyanandam S, et al. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol. 2003;51(3):231–6. PubMed
19.
Zurück zum Zitat Mistro S, et al. Does lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta-analysis. Clin Infect Dis. 2012;54(12):1774–7. CrossRef Mistro S, et al. Does lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta-analysis. Clin Infect Dis. 2012;54(12):1774–7. CrossRef
20.
Zurück zum Zitat Rodríguez MM, et al. Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection. Antimicrob Agents Chemother. 2009;53(12):5022–5. CrossRef Rodríguez MM, et al. Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection. Antimicrob Agents Chemother. 2009;53(12):5022–5. CrossRef
21.
Zurück zum Zitat Rodríguez MM, et al. Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice. Antimicrob Agents Chemother. 2010;54(5):1665–9. CrossRef Rodríguez MM, et al. Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice. Antimicrob Agents Chemother. 2010;54(5):1665–9. CrossRef
Metadaten
Titel
Sphenoidal mucormycosis associated with large B-cell lymphoma: case report and literature review
verfasst von
MD Anis Chaari
Esraa Turak
Mark Nashaat
Islam Aboayana
Vipin Kauts
Publikationsdatum
15.04.2021
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2021
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-021-00705-5